Corrigendum to “SiRNA-based delivery nanoplatform attenuates the CRC progression via HIF1α-AS2” [Nano Today 47 (2022) 101667]

Qingtao Meng(Wuhan University), Rui Chen(Capital Medical University), Hongbao Yang(China Pharmaceutical University), Xiaobo Li(Capital Medical University), Jie Xu(Changzhou University), Yu Zhang(Hainan Medical University), Xinwei Zhang(Southeast University), Hanqing Chen(Capital Medical University), Na Gao(University of Chinese Academy of Sciences), Bo Jiang(Capital Medical University), Jin Xu(Nanjing Maternity and Child Health Care Hospital), Shenshen Wu(China Medical University), Jing Wang(Capital Medical University), Yuanyuan Cao(Capital Medical University)
Nano Today
June 17, 2024
Cited by 0


Related Papers